Company Profile
MIP Technologies is a biotechnology company working at the boundary between chemistry and material science. The Company uses proprietary technology based on molecularly imprinted polymers and other novel chemistries for the development of separation products. In addition to strong know-how and intellectual property, the company has developed a broad technology platform enabling a rapid and economic development of custom made and stand-alone Separation Phases with superior properties. A key advantage of phases based on molecular imprinting is that they are ‘selective’ leading to higher sensitivity, better efficiency and improved productivity in the separation or extraction of chemical compounds from complex mixtures. In addition, the Company develops separation phases based on other types of novel chemistry through the OPUS product line. MIP Technologies is a pioneer in the commercial applications of molecular imprinting and is located in Lund, Sweden.
The privately held Company is owned by Teknoseed, Malmöhus Invest, Catella Healthcare Investment, founders and management.
Mission
To provide innovative products based on molecular imprinting and other novel chemistries that serve industry's needs in analytical, preparative and process scale ‘selective separations’.
Vision
To become the world leader in the development and commercialization of selective separation materials.
Markets targeted
MIP Technologies' analytical and preparative MIP product range, now distributed and co-developed exclusively on a global basis with Supelco Sigma-Aldrich, serves control, analytical or contract research laboratories operating in the food, health, pharma, veterinary and environmental sectors. In the process development area the Company operates independently for development and for large scale production and is open to partnerships with customers in the pharma/biotech, food and commodity industries. For the OPUS product range MIP Technologies is open to partnerships and other commercial arrangements on a product by product basis.
Molecular Imprinting Technology
Molecularly imprinted polymers (MIPs) are a class of highly cross-linked polymer-based molecular recognition elements engineered to bind one target compound or a ‘class’ of structurally related target compounds with high selectivity. Selectivity is introduced during preparation where specific cavities or ‘imprints’, formed around a template molecule, exhibit steric and/or chemical complementary to the target molecule(s).
MIP Product line and pipeline products
MIP Technologies specializes in developing MIP sorbents for a) analytical and preparative applications e.g. solid-phase extraction (SPE) and for b) selective extraction or separation of small molecules, peptides and carbohydrates at the process scale. Process scale separation applications for the Company's technology are found in the pharmaceutical, food processing and commodity/consumables industries.
MIP Technologies' product portfolio consists today of a pipeline of standard analytical SPE products and custom-made separation phases. These products are supplied in multiple formats including small scale pre-packed SPE cartridges, pre-columns for LC/MS or as bulk media for preparative scale applications.
Global distribution of MIP analytical products
MIP Technologies entered into a global distribution and co-development agreement with Supelco Sigma-Aldrich in November 2006 for all products in the analytical and preparative separations field.
OPUS Product line
MIP Technologies has developed a new series of proprietary separation phases targeted at SPE and HPLC applications. These products will cover an extensive fraction of the separation phase landscape with the emphasis on chemical novelty and high performance (see OPUS Products).
Deals and partners
MIP Technologies has several research and development contracts, some under confidentiality, with multi-national blue chip customers in Pharma/Biotech, Food and other industries. It also has, or has had, collaborations or contracts with various international government agencies (eg the US Environmental Protection Agency (USEPA), Centers for Disease Control and Prevention (CDC) in Atlanta; Dutch Food Agency (RIVM).
Production
The Company has a pilot scale facility nearing completion which will allow production runs at the 100+kg scale. Currently, up to 10 kg per week of polymer based phases can be produced under a present environmental permission for 500 kg MIP material annually. A permission for annual production of up to 10 metric tons is pending. Process scale production is carried out with toll manufacturing partners.
Management team
MIP Technologies has a highly experienced senior management team, consisting of Dr. Anthony Rees (CEO and Business Development), Dr. Ecevit Yilmaz (CTO), Dr. Ola Karlsson (VP Production) and Olof Svensson (Financial Officer), who bring to the company a combination of outstanding scientific credentials, global industrial expertise in polymer production and experience of entrepreneurial management and marketing.
